Breaking News Instant updates and real-time market news.

CHEK

Check-Cap

$2.18

-0.03 (-1.36%)

06:37
07/09/19
07/09
06:37
07/09/19
06:37

Check-Cap announces final results from post-CE approval study of C-Scan system

Check-Cap announced final results from its recently completed post-CE approval study evaluating the clinical performance and safety of the C-Scan system. The multi-center, open label, home monitoring, prospective study was designed to determine the performance characteristics of Check-Cap's capsule-based screening test, the C-Scan system, for detecting pre-cancerous polyps compared with the fecal immunochemical test, or FIT, a commonly used non-invasive colorectal cancer screening test; in each case using colonoscopy as the reference method. The study included 90 evaluable patients who either had known polyps or were considered to be of average risk. Each patient ingested a C-Scan capsule and also underwent a FIT and a comparative colonoscopy performed by independent gastroenterologists, who were blinded to the corresponding test's results. The C-Scan clinical evaluation was obtained using the evaluable patient population implementing a gender-based motility analysis and the results of both C-Scan and FIT were compared to colonoscopy. The primary efficacy endpoint of the study was sensitivity and specificity of the C-Scan system compared to FIT in detecting subjects with polyps greater than or equal to 10 mm. The results demonstrate that C-Scan achieved a sensitivity of 76% in patients with polyps greater than or equal to 10 mm, while FIT achieved a sensitivity of 29% in patients with polyps greater than or equal to 10 mm. C-Scan achieved a specificity of 82% in all patients, while FIT achieved a specificity of 96% in all patients. In addition, C-Scan detected all 4 patients with polyps greater than or equal to 40 mm, while the FIT detected only one of the four patients with polyps greater than or equal to 40mm. Overall, C-Scan achieved a sensitivity of 66% in all patients, including patients with polyps less than 10mm, while FIT achieved a sensitivity of 23% in all patients, including patients with polyps less than 10mm. In total, 142 patients enrolled in the study and after factoring in technical and physiological dropouts and protocol violations, the number of evaluable patients was 90. No serious adverse events were reported, and the adverse events were mild in severity. Check-Cap is currently conducting a pilot study in the U.S. to evaluate the safety, usability and subject compliance of the C-Scan system at the New York University School of Medicine and Mayo Clinic. In addition, Check-Cap intends to continue collecting clinical data in additional studies in preparation for its planned pivotal study. Assuming positive pilot study results, the company plans to initiate a pivotal study in people of average risk for polyps and colorectal cancer in mid-2020. The C-Scan system has received CE marking and approval from the Israeli Ministry of Health, the Medical Device Division for marketing in Israel.

CHEK Check-Cap
$2.18

-0.03 (-1.36%)

02/05/19
DOTC
02/05/19
INITIATION
Target $6
DOTC
Buy
Check-Cap initiated with a Buy at Dougherty
Dougherty initiated Check-Cap with a Buy rating and $6 price target.

TODAY'S FREE FLY STORIES

SNAP

Snap

$14.14

0.12 (0.86%)

18:23
07/22/19
07/22
18:23
07/22/19
18:23
Upgrade
Snap rating change  »

Snap upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 03

    Aug

HD

Home Depot

$211.23

-1.79 (-0.84%)

18:22
07/22/19
07/22
18:22
07/22/19
18:22
Hot Stocks
Home Depot CFO: The company is in great hands »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

AN

AutoNation

$42.01

-0.045 (-0.11%)

18:21
07/22/19
07/22
18:21
07/22/19
18:21
Hot Stocks
Breaking Hot Stocks news story on AutoNation »

AutoNation down 2.6%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

AN

AutoNation

$42.01

-0.045 (-0.11%)

18:17
07/22/19
07/22
18:17
07/22/19
18:17
Earnings
AutoNation reports Q2 cont ops EPS $1.12, consensus $1.06 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 13

    Nov

CR

Crane

$86.50

0.99 (1.16%)

18:15
07/22/19
07/22
18:15
07/22/19
18:15
Earnings
Crane backs FY19 adjusted EPS view of $6.25-$6.45, consensus $6.41 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 09

    Sep

  • 09

    Sep

CR

Crane

$86.50

0.99 (1.16%)

18:14
07/22/19
07/22
18:14
07/22/19
18:14
Earnings
Crane Co. reports Q2 EPS ex-items $1.58, consensus $1.56 »

Reports Q2 revenue $842M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 09

    Sep

  • 09

    Sep

AN

AutoNation

$42.01

-0.045 (-0.11%)

, GOOG

Alphabet

$1,138.09

8.09 (0.72%)

18:11
07/22/19
07/22
18:11
07/22/19
18:11
Hot Stocks
AutoNation names Cheryl Miller CEO »

AutoNation (AN) announced…

AN

AutoNation

$42.01

-0.045 (-0.11%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 03

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

18:04
07/22/19
07/22
18:04
07/22/19
18:04
Hot Stocks
Steel Dynamics reports Q2 operating income $295M, down 6% from Q1 »

Q2 average external…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

FBMS

First Bancshares

$29.74

-0.105 (-0.35%)

18:03
07/22/19
07/22
18:03
07/22/19
18:03
Hot Stocks
First Bancshares announces agreement to acquires First Florida Bancorp »

The First Bancshares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

18:03
07/22/19
07/22
18:03
07/22/19
18:03
Hot Stocks
Steel Dynamics CEO sees 'modest growth' for steel consumption in second half »

CEO Mark Millett says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

18:01
07/22/19
07/22
18:01
07/22/19
18:01
Earnings
Steel Dynamics reports Q2 EPS 87c, consensus 89c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

FDEF

First Defiance Financial

$27.22

-0.04 (-0.15%)

17:58
07/22/19
07/22
17:58
07/22/19
17:58
Earnings
First Defiance Financial reports Q2 EPS 61c, consensus 58c »

"Solid loan growth,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

QCOM

Qualcomm

$75.93

0.9 (1.20%)

, INTC

Intel

$51.36

1.1 (2.19%)

17:58
07/22/19
07/22
17:58
07/22/19
17:58
Hot Stocks
Qualcomm falls after news Apple may buy Intel smartphone-modem chip business »

Shares of Qualcomm (QCOM)…

QCOM

Qualcomm

$75.93

0.9 (1.20%)

INTC

Intel

$51.36

1.1 (2.19%)

AAPL

Apple

$207.21

4.59 (2.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 03

    Aug

SPY

SPDR S&P 500 ETF Trust

$297.82

0.65 (0.22%)

, SPX

S&P 500

$0.00

(0.00%)

17:51
07/22/19
07/22
17:51
07/22/19
17:51
General News
Trump tweets budget deal reached with no poison pills »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$297.82

0.65 (0.22%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAFD

Washington Federal

$34.85

-0.12 (-0.34%)

17:46
07/22/19
07/22
17:46
07/22/19
17:46
Hot Stocks
Washington Federal raises dividend 5% »

Washington Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBMS

First Bancshares

$29.74

-0.105 (-0.35%)

17:46
07/22/19
07/22
17:46
07/22/19
17:46
Earnings
First Bancshares reports Q2 EPS ex-items 79c, consensus 69c »

M. Ray "Hoppy"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NTDOY

Nintendo

$0.00

(0.00%)

17:43
07/22/19
07/22
17:43
07/22/19
17:43
Periodicals
Law firm sues Nintendo over Joy-Con drift, Polygon reports »

Chimicles Schwartz Kriner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OEC

Orion Engineered

$18.41

0.05 (0.27%)

17:33
07/22/19
07/22
17:33
07/22/19
17:33
Hot Stocks
Orion Engineered announces price increases »

Orion Engineered Carbons…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 06

    Aug

HMST

HomeStreet

$27.76

-0.03 (-0.11%)

17:31
07/22/19
07/22
17:31
07/22/19
17:31
Earnings
HomeStreet reports Q2 core EPS 13c, consensus 52c »

"The second quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

GLD

SPDR Gold Shares

$134.46

(0.00%)

17:31
07/22/19
07/22
17:31
07/22/19
17:31
Hot Stocks
SPDR Gold Shares holdings rise to 825.18MT from 820.49MT »

This is the 4th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARX

RA Pharmaceuticals

$36.01

2.42 (7.20%)

17:29
07/22/19
07/22
17:29
07/22/19
17:29
Syndicate
RA Pharmaceuticals files to sell $100M of common stock »

Jefferies, BMO Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHE

Benchmark Electronics

$25.05

0.22 (0.89%)

17:29
07/22/19
07/22
17:29
07/22/19
17:29
Hot Stocks
Benchmark Electronics appoints Rob Crawford Chief Revenue Officer »

Benchmark Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

17:28
07/22/19
07/22
17:28
07/22/19
17:28
Periodicals
Apple may pay $1B or more for Intel patents, staff in chip unit deal, WSJ says »

Apple (AAPL) is in…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 03

    Aug

ATVI

Activision Blizzard

$45.57

0.43 (0.95%)

17:26
07/22/19
07/22
17:26
07/22/19
17:26
Hot Stocks
Blizzard co-founder Frank Pearce departing after 28 years »

One of the founders of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 05

    Sep

NBSE

NeuBase Therapeutics

$3.55

-0.58 (-14.04%)

17:25
07/22/19
07/22
17:25
07/22/19
17:25
Hot Stocks
Carnegie Mellon reports 5.5% passive stake in NeuBase Therapeutics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.